Steven M. Paul

University of California, San Francisco — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index6.0kcitations77works3.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(11), Neurotransmitter Receptor Influence on Behavior(9), Neuroscience and Neuropharmacology Research(7), Neuroendocrine regulation and behavior(7), Schizophrenia research and treatment(6)

Publications77 total

EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS
The International Journal of Neuropsychopharmacology·2025· 1 citedOpen Access
Impact of Multimorbidity on Symptom Burden and Symptom Clusters in Patients Receiving Chemotherapy
Cancer Medicine·2025· 11 citedOpen Access
Worse Psychological Profiles Are Associated With Higher Levels of Stress and Symptom Burden in Patients With Cancer During the COVID-19 Pandemic
Oncology nursing forum·2024· 1 cited
The origins of ADNI
Alzheimer s & Dementia·2024· 5 citedOpen Access
Gaining trust through transparency: the EMERGENT-2 trial – Authors' reply
The Lancet·2024· 1 citedOpen Access
Lower Income, Smoking, Cardiopulmonary Comorbidities, and Higher Symptom Burden Influence the Occurrence of Cough in Patients Receiving Chemotherapy
Oncology nursing forum·2024· 1 cited
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
The Lancet·2023· 194 cited
Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial
CNS Spectrums·2023· 9 citedOpen Access
In Memoriam Donald S. Robinson, MD
Neuropsychopharmacology·2022Open Access
Distinct Nausea Profiles Are Associated With Gastrointestinal Symptoms in Oncology Patients Receiving Chemotherapy
Cancer Nursing·2022· 7 citedOpen Access
Efficacy and Safety of Xanomeline, a M1/M4 Receptor Preferencing Agonist, Plus Trospium, a Peripheral Muscarinic Antagonist, in Schizophrenia: Phase 2 Clinical Trial Results
Biological Psychiatry·2020· 6 cited
Predictors of Altered Upper Extremity Function During the First Year After Breast Cancer Treatment
American Journal of Physical Medicine & Rehabilitation·2016· 56 cited
Abstract 12918: Vitamin D Supplementation Did Not Have an Effect on Serum Total or Subclasses of High-Density Lipoprotein-Cholesterol; A Pilot Study
Circulation·2015
Abstract 19717: Patient Characteristics Associated with False Arrhythmia Alarms in Intensive Care
Circulation·2014
Randomized, Controlled Trial to Improve Self-Care in Patients With Heart Failure Living in Rural Areas
Circulation·2014· 101 citedOpen Access
2012 Daniel H. Efron Research Award
2012
Cardiovascular Risk Factors in Deployed Service Members With and Without Acute Coronary Syndromes
The Journal of Cardiovascular Nursing·2011· 2 cited
Gary Tollefson
Neuropsychopharmacology·2009Open Access
A Randomized Clinical Trial to Reduce Patient Prehospital Delay to Treatment in Acute Coronary Syndrome
Circulation Cardiovascular Quality and Outcomes·2009· 146 citedOpen Access
Commentary on “A roadmap for the prevention of dementia: The inaugural Leon Thal Symposium”
Alzheimer s & Dementia·2008· 4 cited
page 1 of 4Next →

Frequent Co-authors

Patricia Painter(6), Phil Skolnick(6), David Pickar(4), Nancy L. Ascher(4), Perry H. Moore(3), Mary B. Engler(3), Marguerite M. Engler(3), Jacqueline N. Crawley(3), Alec Roy(3), R. H. Purdy(2), A. Leslie Morrow(2), Mary J. Malloy(2), Michele Mietus‐Snyder(2), Laurie Carlson(2), Susan Carey(2), Jeffrey Myll(2), Rodrigo Labarca(2), Markku Linnoila(2), L. L. Hector(2), K. M. Ray(2)